It is a biotech. There hasn’t been a biotech on the OTC that has ever made more than a couple their milestones by/within their estimated timelines. Just the complaining about it. Shows anything else talked about lacks credibility. And lack of knowledge of the OTC and business. Unless of course they are getting paid to attack. Most often the case or next in line is they want cheap shares. Which are you?
News 
Market Data 
Discover 
AI
